The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Emergent Biosolutions Inc shares valued at $263,077 were sold by Richard Ronald on Dec 05 ’25. At $11.97 per share, Richard Ronald sold 21,984 shares. The insider’s holdings dropped to 98,417 shares worth approximately $1.14 million following the completion of this transaction.
Also, RONALD RICHARD purchased 32,848 shares, netting a total of over 392,335 in proceeds.
Before that, DeGolyer Donald W had sold 17,801 shares from its account. In a trade valued at $187,623, the Director traded Emergent Biosolutions Inc shares for $10.54 each. Upon closing the transaction, the insider’s holdings decreased to 17,801 shares, worth approximately $1.39 million.
As published in their initiating research note from H.C. Wainwright on December 30, 2024, Emergent Biosolutions Inc [EBS] has been a Buy and the price target has been revised to $15. Analysts at Rodman & Renshaw started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of March 07, 2024, The Benchmark Company has increased its “Hold” rating to a “Buy” for EBS.
Analyzing EBS Stock Performance
On last trading session, Emergent Biosolutions Inc [NYSE: EBS] plunged -0.52% to $11.56. The stock’s lowest price that day was $11.165, but it reached a high of $11.62 in the same session. During the last five days, there has been a drop of approximately -0.34%. Over the course of the year, Emergent Biosolutions Inc shares have jumped approximately 28.30%. Shares of the company reached a 52-week high of $13.41 on 10/30/25 and a 52-week low of $4.02 on 04/09/25.
Support And Resistance Levels for Emergent Biosolutions Inc (EBS)
According to the 24-hour chart, there is a support level at 11.28, which, if violated, would cause prices to drop to 10.99. In the upper region, resistance lies at 11.73. The next price resistance is at 11.90. RSI (Relative Strength Index) is 58.36 on the 14-day chart, showing neutral technical sentiment.
Is Emergent Biosolutions Inc subject to short interest?
Stocks of Emergent Biosolutions Inc saw a sharp rise in short interest on 2025-11-28 jumping by 0.7 million shares to 8.92 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 8.22 million shares. A jump of 7.81% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 6.27 of the overall float, the days-to-cover ratio (short ratio) jumped to 6.27.
Which companies own the most shares of Emergent Biosolutions Inc (EBS)?
In terms of Emergent Biosolutions Inc share price expectations, FactSet research, analysts set an average price target of 51.5 in the next 12 months, up nearly 343.2% from the previous closing price of $11.62. Analysts anticipate Emergent Biosolutions Inc stock to reach 65 by 2025, with the lowest price target being 38. In spite of this, 2 analysts ranked Emergent Biosolutions Inc stock as Buy at the end of 2025.
